Insider Trading & Ownership - Greenleaf Peter

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Greenleaf Peter
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-06
Sale
2024-03-07
4:46 pm
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
126,981$5.6$711,0941,522,114
(Direct)
View
2023-03-02
Sale(A)
2024-02-22
4:15 pm
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
33,047$8.78$290,153982,671
(Direct)
View
2023-03-02
Sale
2023-03-06
4:27 pm
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
32,750$8.94$292,785982,968
(Direct)
View
2022-03-02
Sale
2022-03-04
4:11 pm
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
9,068$12.01$108,907879,395
(Direct)
View
2021-05-11
Purchase
2021-05-12
4:32 pm
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
5,125$10.71$54,89113,453
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-20
Option Award
2024-02-22
4:25 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
661,538$01,649,095
(Direct)
View
2023-03-02
Option Award
2023-03-06
4:27 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
667,407$0982,968
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:22 pm
N/A
N/A
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
79,645$5.60
(Direct)
View
2022-05-24
Disposition
2022-05-26
5:22 pm
N/A
N/A
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
173,517$00
(Direct)
View
2022-03-22
Other
2022-03-22
5:12 pm
N/A
N/A
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
105,034$0105,034
(Direct)
View
2022-03-22
Disposition
2022-03-22
5:12 pm
N/A
N/A
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
206,257$0105,034
(Direct)
View
2022-03-02
Option Award
2022-03-04
4:11 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
874,728$0879,395
(Direct)
View
2022-01-27
Option Award
2022-01-31
6:02 pm
N/A
2023-01-27
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
20,492$0250,119
(Direct)
View
2022-01-27
Exercise
2022-01-31
6:02 pm
N/A
2023-01-27
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
10,246$0250,119
(Direct)
View
2022-01-27
Option Award
2022-01-31
6:02 pm
N/A
2032-01-26
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
114,347$3.66250,119
(Direct)
View
2021-08-06
Exercise
2021-08-10
6:17 pm
N/A
2022-08-01
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
35,000$0112,288
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:22 pm
N/A
2031-06-10
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
48,542$0128,187
(Direct)
View
2021-06-10
Option Award
2021-06-14
6:22 pm
N/A
N/A
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
25,452$4.42128,187
(Direct)
View

Ownership
2021-01-04
5:53 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHGreenleaf Peter
Chief Executive Officer
0$02,838,128
(Direct)
View
2020-08-07
Exercise
2020-08-11
5:03 pm
N/A
2022-08-01
BIODELIVERY SCIENCES INTERNATIONAL INCBDSIGreenleaf Peter
Director
35,000$0112,288
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:02 pm
N/A
2030-06-11
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
58,246$0112,439
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:02 pm
N/A
N/A
ANTARES PHARMA INC.ATRSGreenleaf Peter
Director
30,220$2.73112,439
(Direct)
View
(A) Indicate amendment filing.